HCL Healthcare India

hclhealthcare.in

HCL Healthcare, in affiliation with Johns Hopkins Medicine International, is the healthcare delivery arm of HCL Group. Starting with the country's first nationwide networked multispecialty clinics, HCL Healthcare aims to provide the whole continuum of care for chronic and acute diseases. HCL Healthcare will offer unmatched patient experience and outcomes by adopting global best practices for medical quality and training, using evidence based treatments and integrating advanced technology. HCL Healthcare is determined to be the trusted long term care partner for people in health or illness.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HEALTH TECHNOLOGY

STELLAR HEALTH ANNOUNCES EXPANSION OF VALUE-BASED CARE INITIATIVE FOR HIGHMARK, INC.

Stellar Health | October 19, 2022

news image

Stellar Health a healthcare technology company changing the way health insurers and providers activate value-based care arrangements, announced the expansion of their value-based care initiative with Highmark Inc. upon results of its initial program that improved quality and chronic condition management across Highmark's Medicare Advantage and Commercial lines of business. Stellar announced the collaboration in 2021 to help Highmark accelerate new payment models and value-based ...

Read More

HEALTH TECHNOLOGY

ANTENGENE ANNOUNCES ATG-101 GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA

Antengene Corporation Limited | September 19, 2022

news image

Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...

Read More

HEALTH TECHNOLOGY

HEALTHCARE TRIANGLE PARTNERS WITH GOOGLE CLOUD TO ACCELERATE CLOUD TRANSFORMATION FOR HEALTHCARE AND LIFE SCIENCES ORGANIZATIONS

Healthcare Triangle, Inc. | October 20, 2021

news image

Healthcare Triangle Inc., a leading provider of cloud and data transformation solutions in healthcare and life sciences, is pleased to announce that it has advanced to Google Cloud Premier Partner status. This advancement to ‘Premier’ status is based on its success in building, deploying, and managing Google Cloud solutions for regulated healthcare and life sciences organizations and building massive data analytics platforms on Google Cloud’s highly scalable and reliable inf...

Read More

AI

IMBIO AND RIVERAIN TECHNOLOGIES COLLABORATE TO PROVIDE A COMPREHENSIVE AI-POWERED LUNG HEALTH SOLUTION

Imbio | May 19, 2021

news image

Imbio, a leading medical imaging artificial intelligence (AI) provider for chronic lung and cardiothoracic diseases, and Riverain Technologies, a leader in clinical AI for lung nodules, have announced a collaboration to provide clinicians, health systems, and radiology facilities with a more comprehensive lung health solution through a joint offering of their FDA cleared AI tools. Read More

news image

HEALTH TECHNOLOGY

STELLAR HEALTH ANNOUNCES EXPANSION OF VALUE-BASED CARE INITIATIVE FOR HIGHMARK, INC.

Stellar Health | October 19, 2022

Stellar Health a healthcare technology company changing the way health insurers and providers activate value-based care arrangements, announced the expansion of their value-based care initiative with Highmark Inc. upon results of its initial program that improved quality and chronic condition management across Highmark's Medicare Advantage and Commercial lines of business. Stellar announced the collaboration in 2021 to help Highmark accelerate new payment models and value-based ...

Read More
news image

HEALTH TECHNOLOGY

ANTENGENE ANNOUNCES ATG-101 GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA

Antengene Corporation Limited | September 19, 2022

Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...

Read More
news image

HEALTH TECHNOLOGY

HEALTHCARE TRIANGLE PARTNERS WITH GOOGLE CLOUD TO ACCELERATE CLOUD TRANSFORMATION FOR HEALTHCARE AND LIFE SCIENCES ORGANIZATIONS

Healthcare Triangle, Inc. | October 20, 2021

Healthcare Triangle Inc., a leading provider of cloud and data transformation solutions in healthcare and life sciences, is pleased to announce that it has advanced to Google Cloud Premier Partner status. This advancement to ‘Premier’ status is based on its success in building, deploying, and managing Google Cloud solutions for regulated healthcare and life sciences organizations and building massive data analytics platforms on Google Cloud’s highly scalable and reliable inf...

Read More
news image

AI

IMBIO AND RIVERAIN TECHNOLOGIES COLLABORATE TO PROVIDE A COMPREHENSIVE AI-POWERED LUNG HEALTH SOLUTION

Imbio | May 19, 2021

Imbio, a leading medical imaging artificial intelligence (AI) provider for chronic lung and cardiothoracic diseases, and Riverain Technologies, a leader in clinical AI for lung nodules, have announced a collaboration to provide clinicians, health systems, and radiology facilities with a more comprehensive lung health solution through a joint offering of their FDA cleared AI tools. Read More